Form 4: Ventas CEO Exercises Options, Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Ventas Chairman and CEO Debra A. Cafaro exercised stock options and sold the underlying shares as part of a pre-arranged 10b5-1 trading plan.
Summary
- Debra A. Cafaro, Chairman and CEO of Ventas, Inc. (VTR), reported transactions involving the company's common stock.
- On December 1, 2025, Ms. Cafaro acquired 10,322 shares of Common Stock through the exercise of fully vested stock options at an exercise price of $73.71 per share.
- Concurrently, Ms. Cafaro disposed of 10,322 shares of Common Stock at a weighted average price of $80.5482 per share, with individual sales ranging from $80.13 to $80.81.
- These transactions were executed pursuant to a Rule 10b5-1 trading plan, which was entered into on March 28, 2024.
- The options exercised were scheduled to expire within the next 9 months and had become fully vested on August 3, 2016.
- Following these transactions, Ms. Cafaro directly beneficially owns 1,145,695 shares of Ventas Common Stock.
- Ms. Cafaro also holds 30,966 unexercised stock options to purchase shares of Ventas Common Stock.
Sentiment
Score: 6
Explanation: The transaction is a pre-planned exercise of options and sale of shares, indicating a routine financial management activity rather than a reaction to new company-specific news. The insider profited from the transaction, which is a neutral to slightly positive signal, but the act of selling itself can be viewed neutrally.
Positives
- The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned financial management activity rather than a reaction to new, undisclosed information.
- The sale price of $80.5482 per share was higher than the exercise price of $73.71 per share, indicating a profitable transaction for the insider.
Negatives
- The sale of shares by a key executive, even under a 10b5-1 plan, can sometimes be perceived as a slight reduction in insider conviction, though it is often for personal financial planning or diversification.
Risks
- No specific company-related operational or financial risks are disclosed in this Form 4 filing. The primary 'risk' is the potential for market misinterpretation of routine insider selling.
Future Outlook
No specific forward-looking statements regarding the company's performance or strategic direction are provided in this filing. The reporting person has undertaken to provide full information regarding the number of shares sold at each separate price within the reported range upon request.
Management Comments
- The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024.
Industry Context
This Form 4 filing details a routine insider transaction for a senior executive of a publicly traded company. Such transactions, particularly when executed under a Rule 10b5-1 plan, are common for personal financial management, diversification, or liquidity needs and do not typically reflect specific industry trends or competitive positioning.
Stakeholder Impact
- Shareholders might observe a slight increase in shares available on the market due to the sale, but the impact is minimal given the transaction size relative to total outstanding shares. The transaction is a routine personal financial management activity by a key executive and does not suggest a change in company strategy or performance.
Next Steps
- The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the reported range.
Key Dates
| Date | Description |
|---|---|
| 08/03/2016 | Date stock options became fully vested. |
| 03/28/2024 | Date Rule 10b5-1 trading plan was entered into by the Reporting Person. |
| 12/01/2025 | Date of option exercise and subsequent sale of common stock. |
| 12/03/2025 | Date the Form 4 filing was signed. |
| 08/03/2026 | Expiration date of the exercised stock options. |
Recommendation
holdThis Form 4 reports a routine, pre-planned insider transaction (exercise of options and sale of shares) by the CEO. Such transactions, especially when executed under a 10b5-1 plan, are typically for personal financial management, diversification, or tax purposes and do not usually signal a change in the company's fundamental outlook or warrant a change in investment recommendation. The insider still holds a substantial number of shares and options, indicating continued alignment with shareholder interests.
Keywords
Ventas, VTR, SEC Form 4, Insider Transaction, Stock Options, Debra A. Cafaro, 10b5-1 Plan, Share Sale, CEO, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.